Original Query: ALL
Previous Study | Return to List | Next Study

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01848561
Recruitment Status : Recruiting
First Posted : May 7, 2013
Last Update Posted : March 8, 2018
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 26, 2027
  Estimated Study Completion Date : April 26, 2027